222 related articles for article (PubMed ID: 20421225)
1. Screening for, and management of, possible arrhythmogenic syndromes (channelopathies/ion channel diseases).
Svendsen JH; Geelen P;
Europace; 2010 May; 12(5):741-2. PubMed ID: 20421225
[TBL] [Abstract][Full Text] [Related]
2. Arrhythmogenic hereditary syndromes: Brugada Syndrome, long QT syndrome, short QT syndrome and CPVT.
Schimpf R; Veltmann C; Wolpert C; Borggrefe M
Minerva Cardioangiol; 2010 Dec; 58(6):623-36. PubMed ID: 21135804
[TBL] [Abstract][Full Text] [Related]
3. [Cardiac ion channelopathies: A potential link between cardiomyopathies and cardiac arrhythmias].
Schimpf R; Rudic B; Tülümen E; Papavassiliu T; Dösch C; Borggrefe M
Dtsch Med Wochenschr; 2013 Mar; 138(12):591-7. PubMed ID: 23483420
[No Abstract] [Full Text] [Related]
4. [Sudden cardiac death in athletes with an apparently normal heart: the channelopathies].
Giustetto C; Gaita F
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):78S-82S. PubMed ID: 19195312
[TBL] [Abstract][Full Text] [Related]
5. The genetic and clinical features of cardiac channelopathies.
Roberts JD; Gollob MH
Future Cardiol; 2010 Jul; 6(4):491-506. PubMed ID: 20608822
[TBL] [Abstract][Full Text] [Related]
6. Sudden death and ion channel disease: pathophysiology and implications for management.
Bastiaenen R; Behr ER
Heart; 2011 Sep; 97(17):1365-72. PubMed ID: 21685181
[TBL] [Abstract][Full Text] [Related]
7. Genetics of cardiac arrhythmias.
Cummings S; Priori S
Minerva Med; 2011 Jun; 102(3):209-22. PubMed ID: 21593722
[TBL] [Abstract][Full Text] [Related]
8. The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases.
Mazzanti A; O'Rourke S; Ng K; Miceli C; Borio G; Curcio A; Esposito F; Napolitano C; Priori SG
Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):499-519. PubMed ID: 24650315
[TBL] [Abstract][Full Text] [Related]
9. Management of ventricular arrhythmias in suspected channelopathies.
Obeyesekere MN; Antzelevitch C; Krahn AD
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):221-31. PubMed ID: 25691556
[No Abstract] [Full Text] [Related]
10. [Asymptomatic channelopathies : Risk stratification and primary prophylaxis].
Aweimer A; Mügge A; Akin I; El-Battrawy I
Herzschrittmacherther Elektrophysiol; 2023 Jun; 34(2):101-108. PubMed ID: 37103573
[TBL] [Abstract][Full Text] [Related]
11. Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation.
Napolitano C; Bloise R; Monteforte N; Priori SG
Circulation; 2012 Apr; 125(16):2027-34. PubMed ID: 22529064
[No Abstract] [Full Text] [Related]
12. How to perform and interpret provocative testing for the diagnosis of Brugada syndrome, long-QT syndrome, and catecholaminergic polymorphic ventricular tachycardia.
Obeyesekere MN; Klein GJ; Modi S; Leong-Sit P; Gula LJ; Yee R; Skanes AC; Krahn AD
Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):958-64. PubMed ID: 22203660
[No Abstract] [Full Text] [Related]
13. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II: ventricular arrhythmias, channelopathies and implantable defibrillators.
Heidbüchel H; Corrado D; Biffi A; Hoffmann E; Panhuyzen-Goedkoop N; Hoogsteen J; Delise P; Hoff PI; Pelliccia A;
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):676-86. PubMed ID: 17001205
[TBL] [Abstract][Full Text] [Related]
14. Cardiac channelopathies and sudden infant death syndrome.
Tfelt-Hansen J; Winkel BG; Grunnet M; Jespersen T
Cardiology; 2011; 119(1):21-33. PubMed ID: 21778721
[TBL] [Abstract][Full Text] [Related]
15. Genetics and arrhythmias: diagnostic and prognostic applications.
Monteforte N; Napolitano C; Priori SG
Rev Esp Cardiol (Engl Ed); 2012 Mar; 65(3):278-86. PubMed ID: 22245453
[TBL] [Abstract][Full Text] [Related]
16. Polymorphic ventricular tachycardia--part II: the channelopathies.
Choudhuri I; Pinninti M; Marwali MR; Sra J; Akhtar M
Curr Probl Cardiol; 2013 Dec; 38(12):503-48. PubMed ID: 24262155
[TBL] [Abstract][Full Text] [Related]
17. Channelopathies, genetic testing and risk stratification.
Wilde AAM; Amin A
Int J Cardiol; 2017 Jun; 237():53-55. PubMed ID: 28343764
[TBL] [Abstract][Full Text] [Related]
18. [Why do we need genetics in cardiac rhythmology?].
Rieder M; Castiglione A; Asatryan B; Odening KE
Herzschrittmacherther Elektrophysiol; 2020 Dec; 31(4):394-400. PubMed ID: 32661562
[TBL] [Abstract][Full Text] [Related]
19. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes.
Haïssaguerre M; Extramiana F; Hocini M; Cauchemez B; Jaïs P; Cabrera JA; Farré J; Leenhardt A; Sanders P; Scavée C; Hsu LF; Weerasooriya R; Shah DC; Frank R; Maury P; Delay M; Garrigue S; Clémenty J
Circulation; 2003 Aug; 108(8):925-8. PubMed ID: 12925452
[TBL] [Abstract][Full Text] [Related]
20. Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT).
Singh M; Morin DP; Link MS
Prog Cardiovasc Dis; 2019; 62(3):227-234. PubMed ID: 31078562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
